← Home
/
Spyre Therapeutics, Inc. (SYRE)
Stock Analysis
Spyre Therapeutics, Inc. (SYRE)
SYRE
SYRE · Market data
85.17
-4.18%
Updated: 2026-07-02 18:44 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 100.32. Holding above 77.26 keeps the current thesis intact.
✓
Fundamentals
Insufficient / Insufficient
✓
Price Structure
Constructive
×
Breakout Confirmation
Pending
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
77.26
↗
Break Above
Confirmation improves above resistance.
100.32
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 77.26
What's Driving SYRE?
📈 Technical recovery is improving
Momentum is Neutral. Watch 100.32 for confirmation and 77.26 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 77.26
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Insufficient
●
Profitability
Insufficient
💵 Revenue
0.00
≈ Insufficient
📈 Net Income
-69.00M
≈ Insufficient
🧮 EPS (Basic)
1.06
≈ Insufficient
Note: This is an algorithmic technical snapshot, not financial advice.